Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 3:04 AM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1633–1656 of 8,040 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: RNA Clear all

Conditions: Influenza Vaccine
Interventions: Cam2020 M2SR H3N2 influenza vaccine, Fluzone HD IIV, IN Placebo, IM Placebo; Biological · Other
Lead sponsor: FluGen Inc; Industry
Eligibility: 65 Years to 85 Years
Enrollment: 303 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022
U.S. locations: 6
States / cities: Port Orange, Florida • Meridian, Idaho • Lenexa, Kansas + 3 more

Conditions: Hiv, Tobacco Use
Interventions: EX+, Varenicline, HR, TAU; Behavioral · Drug
Lead sponsor: Montefiore Medical Center; Other
Eligibility: 40 Years to 79 Years
Enrollment: 400 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2024 – 2027
U.S. locations: 1
States / cities: The Bronx, New York

Conditions: HIV Infections, Pregnancy Related
Interventions: Abbreviated HIV test counseling; Procedure
Lead sponsor: University of California, San Francisco; Other
Eligibility: 16 Years and older · Female only
Enrollment: 281 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2006 – 2008
U.S. locations: 1
States / cities: San Francisco, California

Conditions: Hiv, Mental Health Issue, Support, Family
Interventions: MPowerment PrEP Promotion Intervention; Behavioral
Lead sponsor: George Mason University; Other
Eligibility: 18 Years and older · Male only
Enrollment: 120 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2026
U.S. locations: 1
States / cities: Fairfax, Virginia

Conditions: Zika
Interventions: Zika Virus Purified Inactivated Vaccine, Placebo; Biological · Other
Lead sponsor: Kathryn Stephenson; Other
Eligibility: 18 Years to 50 Years
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2016 – 2018
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Acquired Immunodeficiency Syndrome, HIV Infections, Depression
Interventions: Massage Therapy; Procedure
Lead sponsor: National Center for Complementary and Integrative Health (NCCIH); NIH
Eligibility: 16 Years and older
Enrollment: 90 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2004
U.S. locations: 1
States / cities: Los Angeles, California

Conditions: Renal Failure Chronic, Hepatitis C
Interventions: glecaprevir/pibrentasvir treatment; Drug
Lead sponsor: Raymond Chung; Other
Eligibility: 21 Years to 65 Years
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2021
U.S. locations: 7
States / cities: Chicago, Illinois • Baltimore, Maryland • Boston, Massachusetts + 4 more

Conditions: Hepatitis C, Cirrhosis
Interventions: Not listed
Lead sponsor: National Institutes of Health Clinical Center (CC); NIH
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2009
U.S. locations: 3
States / cities: Washington D.C., District of Columbia • Bethesda, Maryland • Falls Church, Virginia

Conditions: COVID-19
Interventions: Facilitated Self-Sampling Intervention (FSSI), Testing Navigation Intervention (TNI)., Control; Behavioral
Lead sponsor: The University of Texas Health Science Center, Houston; Other
Eligibility: 18 Years and older
Enrollment: 1,232 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2023 – 2024
U.S. locations: 3
States / cities: Brownsville, Texas • Houston, Texas • Tyler, Texas

Conditions: Hepatitis D
Interventions: EBP921; Drug
Lead sponsor: Eiger BioPharmaceuticals; Industry
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2013
U.S. locations: 2
States / cities: San Francisco, California • Detroit, Michigan

Conditions: HIV Infection, Sexually Transmitted Diseases
Interventions: Health Improvement Project for Teens on HIV Prevention; Behavioral
Lead sponsor: University of Rochester; Other
Eligibility: 15 Years to 19 Years · Female only
Enrollment: 640 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2004 – 2009
U.S. locations: 1
States / cities: Rochester, New York

Conditions: Seasonal Influenza, Cough, Sore Throat, Nasal Congestion, Myalgia, Headache, Fatigue
Interventions: Peramivir; Drug
Lead sponsor: BioCryst Pharmaceuticals; Industry
Eligibility: 6 Years and older
Enrollment: 234 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2009 – 2011
U.S. locations: 79
States / cities: Dothan, Alabama • Mobile, Alabama • Jonesboro, Arkansas + 76 more

Conditions: HIV Infections
Interventions: Nevirapine; Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
U.S. locations: 3
States / cities: San Diego, California • Worcester, Massachusetts • Minneapolis, Minnesota

Conditions: Covid19
Interventions: Niclosamide, Placebo; Drug
Lead sponsor: Entero Therapeutics; Industry
Eligibility: 18 Years and older
Enrollment: 166 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2023
U.S. locations: 13
States / cities: Birmingham, Alabama • DeLand, Florida • Hialeah, Florida + 7 more

Conditions: Loneliness
Interventions: Mindfulness Alone (MO) Intervention, Mindfulness + Compassion Intervention (MC); Behavioral
Lead sponsor: University of Texas at Austin; Other
Eligibility: 18 Years to 70 Years
Enrollment: 91 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2021
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Influenza
Interventions: Inactivated Influenza A Vaccine A/H5N1, Placebo (IM), Placebo (ID); Biological · Drug
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 49 Years
Enrollment: 227 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Houston, Texas

Conditions: Varicella, Rubella, Mumps, Measles
Interventions: Priorix-Tetra™ (MMRV vaccine 208136), ProQuad®, Havrix®, Prevnar®; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 12 Months to 14 Months
Enrollment: 1,851 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2007 – 2009
U.S. locations: 141
States / cities: Birmingham, Alabama • Tuscaloosa, Alabama • Phoenix, Arizona + 125 more

Conditions: Influenza
Interventions: Baloxavir Marboxil; Drug
Lead sponsor: Hoffmann-La Roche; Industry
Eligibility: Up to 1 Year
Enrollment: 49 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 8
States / cities: Jonesboro, Arkansas • Tampa, Florida • Idaho Falls, Idaho + 5 more

Conditions: Distress, Emotional, Emotional Dysfunction, Anxiety, Depression
Interventions: Emotion Regulation Training via Telehealth; Behavioral
Lead sponsor: Teachers College, Columbia University; Other
Eligibility: 18 Years to 65 Years
Enrollment: 134 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2020 – 2024
U.S. locations: 1
States / cities: New York, New York

Conditions: SARS-CoV-2, COVID-19
Interventions: Not listed
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 6 Months and older
Enrollment: 927,004 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2023
U.S. locations: 1
States / cities: Pasadena, California

Conditions: Fractures, Bone
Interventions: Blood draws to assess RNA expression levels; Other
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 110 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2028
U.S. locations: 7
States / cities: Sacramento, California • Bloomington, Indiana • Columbia, Missouri + 4 more

Conditions: Influenza
Interventions: QIVc, TIV1c, TIV2c; Biological
Lead sponsor: Novartis Vaccines; Industry
Eligibility: 4 Years to 18 Years
Enrollment: 2,333 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2013 – 2014
U.S. locations: 88
States / cities: Huntsville, Alabama • Mobile, Alabama • Chandler, Arizona + 73 more

Conditions: COVID-19, Diabetes Mellitus, COVID-19 Pneumonia, COVID-19 Respiratory Infection
Interventions: No Intervention; Other
Lead sponsor: Arrowhead Regional Medical Center; Other
Eligibility: 18 Years to 99 Years
Enrollment: 589 participants
Timeline: 2021 – 2022
U.S. locations: 1
States / cities: Colton, California

Conditions: Influenza
Interventions: Instramuscular vaccine; Biological
Lead sponsor: Medicago; Industry
Eligibility: 65 Years and older
Enrollment: 209 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2020 – 2022
U.S. locations: 14
States / cities: Huntsville, Alabama • Chandler, Arizona • San Diego, California + 11 more

Search by objective public record fields.

Safety and Immunogenicity of Cam2020 M2SR H3N2 Monovalent Influenza Vaccine Alone or With Licensed IIV in Older Adults

Trial of a Harm Reduction Strategy for People With HIV Who Smoke Cigarettes

HIV Testing Strategies in the Perinatal Setting

PrEP Intervention in Prince George's County, Maryland

Zika Virus Purified Inactivated Vaccine (ZPIV) Accelerated Vaccination Schedule Study

Treatment of Depression With Massage in HIV

Multi-center Study to Transplant Hepatitis-C Infected Kidneys

Transplant-Related Accelerated Progression of Hepatitis C

Examining How a Facilitated Self-Sampling Intervention and Testing Navigation Intervention Influences COVID-19 Testing

Proof-of-concept Study Evaluating the Safety and Efficacy of EBP921 in Delta Hepatitis (HDV)

Maintaining HIV Prevention Gains in Female Adolescents

Safety Study of IV Peramivir in Hospitalized Subjects With Confirmed or Suspected Influenza

The Safety and Effectiveness of BI-RG-587 in HIV-Infected Patients

Safety and Efficacy of Niclosamide in Patients With COVID-19 With Gastrointestinal Infection

Preliminary Efficacy of a One-Session Mindfulness Telehealth Intervention for Loneliness

Higher Dose Intradermal H5 Vaccine

Immunogenicity and Safety of GlaxoSmithKline Biologicals' MMRV Vaccine vs. ProQuad® in Children 12-14 Months of Age

Study to Assess the Safety, Pharmacokinetics, and Efficacy of Baloxavir Marboxil in Healthy Pediatric Participants From Birth to < 1 Year With Influenza-Like Symptoms

Emotion Regulation Training Via Telehealth During the COVID-19 Pandemic

A Study of the Effectiveness of Moderna COVID-19 Vaccine

855303-RNA Biomarker Validation

Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

Insulin Regulation and Severity of Severe Acute Respiratory Syndrome COVID-19 Infection

Adjuvanted Seasonal Recombinant Quadrivalent Virus-Like Particles (QVLP) Influenza Vaccine in Adults 65 Years of Age and Older